Syncom Formulations India Ltd-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/11/2025 ,inter alia, to consider and approve Corporate Announcement ....
SYNCOMF · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Syncom Formulations India has notified the stock exchanges about a Board Meeting scheduled for Wednesday, 12 November 2025 at 3:00 PM at its corporate office in Indore. The Board will consider and approve the standalone and consolidated unaudited financial results for the quarter and half year ended 30 September 2025. It will also take on record the limited review report by the auditors, and approve the unaudited statement of assets and liabilities as well as the cash flow statement for the half year ended 30 September 2025. The trading window for insiders remains closed during this period. The financial results themselves are not yet disclosed in this filing.
This is a routine advance notice ahead of the company's Q2/H1 FY26 earnings release. Shareholders should watch for the actual results to be published after the board meeting on 12 November for any meaningful impact on the stock.